Episode

The Human Factor

Podcast
The Collators
Published
May 21, 2026
Duration seconds
3833
Processing state
not_requested
Canonical source
https://thecollators.com/s2e12
Audio
https://traffic.libsyn.com/secure/2e8c179d-6d2c-4b0b-a52f-0ba80b14fdac/20260508_Final.mp3?dest-id=5118630
JSON
/v1/public/podcasts/the-collators-7459521/episodes/the-human-factor
Markdown
/podcast/the-collators-7459521/the-human-factor.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-collators-7459521/episodes/the-human-factor/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-collators-7459521/the-human-factor.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Mark and Howard are joined by Sarah Holland, Chief Business Officer at Swiss biotech CDR Life and President of the Swiss Healthcare Licensing Group, to explore what intelligence looks like in the private sector. Sarah explains how biotech companies use competitive intelligence, scientific data, market insight, expert networks, conferences, regulatory signals, and even industry gossip to make high-stakes decisions about drug development and partnerships.